French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
Details
Serval ID
serval:BIB_AA7C8F9CEC50
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
Journal
Journal of Gene Medicine
Working group(s)
European Society of Gene Therapy
ISSN
1099-498X (Print)
ISSN-L
1099-498X
Publication state
Published
Issued date
2003
Volume
5
Number
1
Pages
82-84
Language
english
Notes
Publication types: Journal ArticlePublication Status: ppublish. Nicole Deglon fait partie de European Society of Gene Therapy. pdf type: SOCIETY COMMUNICATION
Keywords
Clinical Trials Data Monitoring Committees, Clinical Trials as Topic, Europe, Genetic Diseases, X-Linked/genetics, Genetic Diseases, X-Linked/therapy, Genetic Therapy/adverse effects, Genetic Therapy/legislation & jurisprudence, Humans, Severe Combined Immunodeficiency/genetics, Severe Combined Immunodeficiency/therapy
Pubmed
Web of science
Create date
13/12/2011 18:04
Last modification date
23/11/2023 12:19
Usage data
